Ryuji Yasumatsu

Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

Mioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda et al. · Oral Oncology · 2019 · 91 citations · Full text

Medicine, Immunology, Immune Checkpoint Inhibitor +10

Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells

Ryuji Yasumatsu, Torahiko Nakashima, Muneyuki Masuda et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 88 citations · Full text

Tumor Biology, Oncology, Angiogenesis +10

Imbalance between Cysteine Proteases and Inhibitors in a Baboon Model of Bronchopulmonary Dysplasia

Ozden Altiok, Ryuji Yasumatsu, Gulbin Bingol-Karakoc et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 76 citations · Full text

Maspin expression in stage I and II oral tongue squamous cell carcinoma

Ryuji Yasumatsu, Torahiko Nakashima, Naoya Hirakawa et al. · Head & Neck · 2001 · 68 citations

A Role for Matrix Metalloproteinase 9 in IFNγ-Mediated Injury in Developing Lungs

Anantha Harijith, Rayman Choo-Wing, Sule Çataltepe et al. · American Journal of Respiratory Cell and Molecular Biology · 2011 · 60 citations · Full text